D-Leucine
D-Leucine is a more potent anti-seizure agent than L-leucine. D-leucine potently terminates seizures even after the onset of seizure activity. D-leucine, but not L-leucine, reduces long-term potentiation but had no effect on basal synaptic transmission in vitro[1].
Product Specifications
CAS Number
328-38-1
Product Name Alternative
(R) -Leucine
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Endogenous Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/d-leucine.html
Purity
98.0
Solubility
DMSO : < 1 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : 10 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
N[C@H](CC(C)C)C(O)=O
Molecular Formula
C6H13NO2
Molecular Weight
131.18
Precautions
H302, H315, H319, H335
References & Citations
[1]Xiaoyu Cao, et al. Combination of PARP Inhibitor and Temozolomide to Suppress Chordoma Progression. J Mol Med (Berl) . 2019 Aug;97 (8) :1183-1193
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Chromosome 4 Open Reading Frame 14 (NOA1) Antibody (Biotin)
Chromosome 4 Open Reading Frame 14 (NOA1) Antibody (Biotin)
Chromosome 4 Open Reading Frame 14 (NOA1) Antibody (Biotin)
Chromosome 4 Open Reading Frame 14 (NOA1) Antibody (Biotin)